April 15 (Reuters) - BioCardia Inc BCDA.O:
BIOCARDIA ANNOUNCES POSITIVE DSMB REVIEW OF CARDIALLO ALLOGENEIC CELL THERAPY FOR HEART FAILURE PHASE 1/2 CLINICAL TRIAL
BIOCARDIA INC: PLANS TO PROGRESS TRIAL TO ENROLLMENT OF 39 PARTICIPANTS IN UNITED STATES
Source text: ID:nGNX4Vlw0
Further company coverage: BCDA.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.